Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
Penicillin (beta-lactam)
|
Target: cell wall peptidoglycan
Characteristics: mimics end of tetrapeptide crosslink, causing weak points in cell wall and eventually lysis |
|
Cephalosporins (beta-lactam)
|
Target: cell wall/peptidoglycan
characteristics: derived from a mold, inhibition of transpeptidation (crosslinking) of glycan chains |
|
Carbapenem (beta-lactam)
|
Target: cell wall/peptidoglycan
Characteristics: inhibtion of crosslinking of tetrapeptide chains attached to N-acetyluramic acid |
|
Vancomycin
|
Target: cell wall/peptidoglycan
characteristics: attacks gram +, blocks transpeptidation by binding directly to peptide chains, resistant to beta-lactamases, reserved for serious infections |
|
Bacitracin
|
Target: cell wall/peptidoglycan
characteristics: inhibits transport of peptidoglycan precursors, topical use |
|
Cycloseriine
|
target: cell wall/peptidoglycan
characteristics: inhibits synthesis of peptidoglycan precursors |
|
Fosfomycin
|
target: cell wall/peptidoglycan
characteristics: inhibits an enzyme required for peptidoglycan synthesis |
|
Streptomycin (aminoglycosides)
|
target: protein synthesis
characteristics: used to treat bubonic plague, TB, tularemia |
|
Tetracyclines
|
Subgroups: aureomycin, doxycyclin, minocycline, tetracycline
target: protein synthesis characteristics: blocks the attachment of tRNA to the ribosome, preferentially transported into prokaryotes, wide variety of diseases, can cause tooth discoloration (kids), diarrhea/enterocolitis, photosensitization |
|
Erythromycin (macrolide)
|
target: protein synthesis
characteristics: broad spectrum, used for mycoplasma, legionella, chylamidia, pertussis, diptheria |
|
Clarithromycin (macrolide)
|
target: protein synthesis
characteristics: broad spectrum, used for inner ear, respiratory, skin infections |
|
Azithromycin (macrolide)
|
target: protein synthesis
characteristics: broad spectrum, used for inner ear, respiratory, skin |
|
Clindamycin (macrolide)
|
target: protein synthesis
characteristics: derivative of lincomycin, used for severe abdomen/large infections with bacteroides or clostridium (unresponsive to other antibiotics), penicillin resistant staphlococus, skin acne treatments, problem with adverse reactions in GI tract |
|
Aminoglycosides
|
subgroups: streptomycin, gentamicin, tobramycin, neomycin
target: protein synthesis characteristics: blocks the initiations of translation and causes the misreading of mRNA, broad spectrum, mostly used on gram +, can be combined with beta lactam for better penetration, can cause hearing loss, kidney damage, diahrrea/enterocolitis |
|
Chloramyphenicol
|
subgroups: sterptomyces antibiotic
target: protein synthesis characteristics: prevents peptide bonds from being formed, broad spectrum, potentially fatal toxicity (aplastic anemia), reserved for typhoid fever and brain abscesses, can't be given long term |
|
Synercid (streptogramins)
|
target: protein synthesis
characteristics: streptogramin class of drugs, effective against staphylococcus and enterococcus, used for endocarditis and surgical infections as well as streptococus( resistant to other antibiotics) |
|
Fluroquinolones
|
target: nucleic acid synthesis
characteristics: inhibits DNA replication, bactericidal and broad spectrum |
|
Rifamycin
|
target: nucleic acid synthesis
characteristics: inhibits RNA polymerase, treatment for GM+, mycobacteria, and neisemia prophylaxis |
|
Sulfa drugs (sulfonamides)
|
target: folic acid synthesis
characteristics: competitive inhibitor of enzyme in pathway, humans don't have enzyme, can crystallize in kidney and form stones |
|
Trimethoprim
|
target: nucleotide biosynthesis
characteristics: inhibits next step in pathway, synergistic with Sulfa, used for PCP in AIDS |
|
Streptogramins
|
subgroup: synercid
target: protein synthesis characteristics:each interferes with a distinct step of protein synthesis |
|
Oxazolidinones
|
target: protein synthesis
characteristics: thought to interfere with the initiation of protein synthesis |
|
Lincosamides
|
target; protein synthesis
characteristics: prevents the continuation of protein synthesis |
|
Macrolides
|
subgroups: erythromycin, clindamycin, clarithromycin, azithromycin
target: protein synthesis characteristics: prevents the continuation of protein synthesis |
|
Alcohol
|
Target microbe: bacteria, some viruses
concentration: 50-95% (70%) attacks: membranes, protein used on: surfaces, skin |
|
aldehydes
|
target microbes: all, if used long enough
concentration: 2% (glutaraldehyde) 37% (formaldehyde) attacks: protein, nucleic acid used on: surfaces, materials, vaccines |
|
biquanides
|
target microbes: bacteria fungi
attacks: membranes used on: skin, beauty |
|
ethylene oxide
|
target microbes: all of them
concentration: gas attacks: proteins used on: surgical items, plastics |
|
halogens (Cl, I)
|
target microbes: all
concentration: .6ppm or higher attacks: protein used on: surfaces, water |
|
Metals
|
concentration: Ag (<2%) and Hg (<.2%)
attacks: enzymes used on: industrial, medicinal |
|
ozone
|
attacks: membranes
used on: water |
|
peroxygens
|
target microbes: all
concentration: 3% attacks: membranes used on: surfaces |
|
lysol
|
target microbes: some bacteria, mycobacteria, viruses
concentration; 5-19% attacks: membranes, proteins used on: surfaces/skin |
|
quanternary ammonium
|
target microbes: bacteria (not mycobacteria) or pseudomonas
concentration: 1:100-1:1000 attacks: membranes used on: surfaces |
|
chemotherapeutic drug
|
anyy chemical used in the treatment, relief, or prophylaxis of a disease
|
|
prophylaxis
|
use of a drug to pprevent imminent infection of a personat risk
|
|
antimicrobial chemotherapy
|
the use of chemotherapeutic drugs to control infection
|
|
antimicrobials
|
all-inclusive term for any antimicrobial drug, regardless of its origin
|
|
antibiotics
|
substances produced by natureal metabolic processes of some MOs that can inhibit or detroy other MOs
|
|
semisynthetic drugs
|
drugs taht are chemically modified in the laboratory after being isolated from natural sources
|
|
synthetic drugs
|
drugs produced entirely by chemical reactions
|
|
narrow spectrum
|
antimicrobials effective against a limited array of microbial types-for example, a drug effective mainly on gram-positive bacteria
|
|
broad spectrum
|
antimicrobials effective againsta wide variety of microbial types-for example, a drug effective against both gram-positive and gram-negative bacteria
|